X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2927) 2927
Newsletter (198) 198
Publication (176) 176
Book Review (44) 44
Book Chapter (25) 25
Newspaper Article (23) 23
Magazine Article (15) 15
Trade Publication Article (3) 3
Conference Proceeding (2) 2
Dissertation (2) 2
Transcript (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
omalizumab (2854) 2854
humans (1757) 1757
index medicus (1238) 1238
asthma (1129) 1129
allergy (1116) 1116
immunology (932) 932
female (732) 732
asthma - drug therapy (726) 726
male (687) 687
adult (629) 629
immunoglobulin e (561) 561
antibodies, monoclonal, humanized (557) 557
antibodies, monoclonal - therapeutic use (529) 529
middle aged (527) 527
treatment outcome (512) 512
anti-asthmatic agents - therapeutic use (506) 506
antibodies, anti-idiotypic (456) 456
anti-allergic agents - therapeutic use (426) 426
antibodies, anti-idiotypic - therapeutic use (402) 402
ige (398) 398
immunoglobulin e - immunology (384) 384
urticaria (380) 380
omalizumab - therapeutic use (355) 355
child (352) 352
antibodies, monoclonal, humanized - therapeutic use (340) 340
adolescent (339) 339
immunotherapy (337) 337
therapy (337) 337
anti-ige (334) 334
asthma - immunology (328) 328
efficacy (322) 322
care and treatment (313) 313
allergies (306) 306
respiratory system (297) 297
quality of life (296) 296
monoclonal antibodies (295) 295
children (294) 294
drug therapy (282) 282
dermatology (275) 275
allergy and immunology (274) 274
aged (271) 271
immunoglobulin e - blood (261) 261
urticaria - drug therapy (259) 259
chronic disease (257) 257
animals (243) 243
patients (242) 242
severity of illness index (242) 242
quality-of-life (236) 236
research (235) 235
double-blind (231) 231
anti-ige antibody (220) 220
young adult (204) 204
medical research (199) 199
inflammation (198) 198
safety (184) 184
asthma - physiopathology (179) 179
medicine, experimental (179) 179
abridged index medicus (176) 176
severe allergic-asthma (175) 175
pharmacology & pharmacy (170) 170
management (169) 169
fc-epsilon-ri (168) 168
diagnosis (167) 167
medicine, general & internal (166) 166
severe asthma (165) 165
analysis (164) 164
exacerbations (157) 157
monoclonal-antibody (156) 156
anti-asthmatic agents - adverse effects (155) 155
internal medicine (155) 155
chronic idiopathic urticaria (149) 149
asthma - therapy (148) 148
severe persistent asthma (148) 148
allergic-asthma (146) 146
clinical trials (143) 143
adrenal cortex hormones - therapeutic use (142) 142
anti-asthmatic agents - administration & dosage (141) 141
mepolizumab (141) 141
pediatrics (140) 140
medicine & public health (138) 138
anaphylaxis (133) 133
chronic spontaneous urticaria (131) 131
rhinitis (131) 131
allergens (129) 129
antibodies, monoclonal - administration & dosage (129) 129
antibodies, monoclonal - adverse effects (126) 126
studies (125) 125
allergens - immunology (123) 123
asthma - diagnosis (123) 123
dosage and administration (122) 122
antihistamines (121) 121
allergic rhinitis (120) 120
allergic asthma (118) 118
chronic urticaria (116) 116
food allergy (116) 116
corticosteroids (113) 113
expression (113) 113
double-blind method (110) 110
angioedema (107) 107
disease (107) 107
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2793) 2793
German (100) 100
French (91) 91
Spanish (54) 54
Italian (34) 34
Polish (32) 32
Japanese (26) 26
Korean (16) 16
Portuguese (12) 12
Czech (7) 7
Turkish (7) 7
Chinese (6) 6
Danish (4) 4
Croatian (3) 3
Dutch (3) 3
Hebrew (2) 2
Hungarian (2) 2
Russian (2) 2
Slovenian (2) 2
Swedish (2) 2
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Biological Chemistry, ISSN 0021-9258, 06/2017, Volume 292, Issue 24, pp. 9975 - 9987
Immunoglobulin E and its interactions with receptors Fc is an element of RI and CD23 play a central role in allergic disease. Omalizumab, a clinically approved... 
RECEPTOR COMPLEXES | DOMAIN | FC-EPSILON-RI | CONFORMATIONAL-CHANGES | AFFINITY | CRYSTAL-STRUCTURE | BENT | BIOCHEMISTRY & MOLECULAR BIOLOGY | MONOCLONAL-ANTIBODY | MAMMALIAN-CELLS | BINDING | Surface Plasmon Resonance | Omalizumab - genetics | Recombinant Fusion Proteins - pharmacology | Immunoglobulin Fc Fragments - metabolism | Humans | Omalizumab - metabolism | Crystallography, X-Ray | Recombinant Fusion Proteins - metabolism | Receptors, IgE - chemistry | Immunoglobulin E - genetics | Immunoglobulin Fab Fragments - metabolism | Fluorescence Resonance Energy Transfer | Protein Interaction Domains and Motifs | Recombinant Proteins - metabolism | Anti-Asthmatic Agents - pharmacology | Omalizumab - chemistry | Pliability | Immunoglobulin Fab Fragments - genetics | Immunoglobulin E - metabolism | Protein Refolding | Solubility | Models, Molecular | Receptors, IgE - antagonists & inhibitors | Recombinant Proteins - chemistry | Immunoglobulin Fc Fragments - chemistry | Recombinant Fusion Proteins - chemistry | Recombinant Proteins - pharmacology | Immunoglobulin Fab Fragments - pharmacology | Immunoglobulin E - chemistry | Point Mutation | Receptors, IgE - metabolism | Immunoglobulin Fab Fragments - chemistry | Omalizumab - pharmacology | Allosteric Site | Immunoglobulin Fc Fragments - pharmacology | Protein Conformation | Immunoglobulin Fc Fragments - genetics | Amino Acid Substitution | X-ray crystallography | Immunology | antibody | immunoglobulin E (IgE) | allergy | omalizumab | allosteric regulation
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 136, Issue 6, pp. 1476 - 1485
Journal Article
ARTHRITIS & RHEUMATOLOGY, ISSN 2326-5191, 04/2017, Volume 69, Issue 4, pp. 872 - 872
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 01/2015, Volume 135, Issue 1, pp. 67 - 75
ASTERIA I was a 40-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of subcutaneous omalizumab as add-on therapy... 
DIAGNOSIS | THERAPY | ANTI-IGE OMALIZUMAB | CHRONIC IDIOPATHIC URTICARIA | DERMATOLOGY
Journal Article
Journal Article
Journal Article